(Q57226981)

2

0 references

Kui Son Choi

3

0 references

Hoo-Yeon Lee

4

0 references

Jeongseon Kim

5

0 references

language of work or name

English

0 references

publication date

December 2010

0 references

13 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

20947465

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20947465

full work available at URL

2 August 2024

https://api.elsevier.com/content/article/PII:S1877782110001633?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

https://api.elsevier.com/content/article/PII:S1877782110001633?httpAccept=text/plain

2 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

2 August 2024

34

6

713–6

13 October 2010

1 reference

National Center for Biotechnology Information

PubMed publication ID

20947465

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20947465

A review of human carcinogens--Part B: biological agents

2 August 2024

volume

34

0 references

issue

6

0 references

page(s)

713-6

0 references

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma

2 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Environmental factors and risk for hepatocellular carcinoma

2 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

2 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

2 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

2 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population

2 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Cancer control activities in the Republic of Korea

2 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma

2 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

2 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Chronic hepatitis B virus infection in Asian countries

2 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey

2 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea.

2 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

The majority of hepatitis B carriers are not on regular surveillance in Singapore

2 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANEP.2010.09.003

2 August 2024

Identifiers